UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Clinical trials for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA explained in plain language.
Never miss a new study
Get alerted when new UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA trials appear
Sign up with your email to follow new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One pill to fight malaria? new drug trial tests Single-Dose treatment
Disease control CompletedThis study tested a new experimental malaria drug called INE963. It involved 52 adults with uncomplicated malaria to see how quickly a single oral dose could clear the malaria parasites from their blood and to check if it was safe. The goal was to find an effective dose for a sim…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New malaria pill tested against leading treatment in major global trial
Disease control CompletedThis study tested whether a new malaria drug called KLU156 works as well as the current standard treatment, Coartem. It involved 1720 adults and children with uncomplicated malaria. The goal was to see if taking KLU156 once daily for three days clears the infection safely and eff…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New malaria combo fights parasites in Head-to-Head trial
Disease control CompletedThis study tested whether a new two-drug combination (Cipargamin + KLU156) works as well as the standard malaria treatment (Coartem). It involved 60 adolescents and adults with uncomplicated malaria. Researchers measured how quickly and completely the drugs cleared the malaria pa…
Matched conditions: UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC